PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> 1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
1 In 4 Health Care Facilities Lacks Basic Water Services – UNICEF, WHO 03/04/2019 Editorial team [WHO News Release] One in four health care facilities around the world lacks basic water services, impacting over 2 billion people, according to a new report by WHO and UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP). The WHO/UNICEF JMP report, WASH in Health Care Facilities, is the first comprehensive global assessment of water, […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> Posts navigation Older Posts Newer Posts